Adventrx Pharmaceuticals, Inc.
Adventrx closes merger with SD Pharmaceuticals
Published in Lab Law Weekly, June 9th, 2006
Adventrx acquired all outstanding shares of SD Pharma, obtaining worldwide intellectual property rights, excluding rights for China, Taiwan, Hong Kong and Macau, to a portfolio of eight oncology and infectious disease therapeutic product candidates. These candidates include SDP-012 (ANX-530, vinorelbine emulsion), which was the subject of a prior license agreement between the companies, announced in October 2005.
Most of these SD Pharma compounds are novel nano-emulsion formulations of currently...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2006-06-09)
More Articles from Lab Law Weekly
- Avian Influenza
Infants or adults? U.S. NIH ethicists argue for new avian influenza priorities - Bain & Company
New Bain & Company survey shows China looms large as India's pharma competition - Bambino Gesu Children's Hospital, Rome
Closure of the ductus arteriosus involves synthetic smooth muscle cells positive for CD44-v6 - Centre Hospitalier de l'Universite de Clermont Ferrand
Analgesic action of acetaminophen might involve serotonergic system - Chelsea Therapeutics International, Ltd.
Chelsea Therapeutics seeks to develop Droxidopa for neurogenic orthostatic hypotension - Claim Check
Claim Check announces the release of Claim-Alert for combatting costs and speeding settlements - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
